The dietary supplement industry is a global market worth over $170 billion annually, and it is projected to exceed $240 billion by 2028. Millions of people take supplements daily, many without clear evidence that they need them. Meanwhile, certain populations with genuine deficiencies go unaddressed. The gap between supplement marketing and supplement science is enormous.
This article provides an evidence-based reference guide to more than 30 common dietary supplements. For each, we assess the strength of evidence for its most common claimed benefits, identify who actually needs it, note important drug interactions, and provide dosage guidance based on established recommendations. Our evidence ratings follow a framework inspired by the methodology used by the National Institutes of Health Office of Dietary Supplements (NIH ODS) and Examine.com, two of the most rigorous independent sources for supplement evidence.
Understanding Evidence Ratings
Throughout this guide, each supplement receives an evidence rating for its primary claimed benefit:
| Rating |
Meaning |
What It Tells You |
| Strong |
Multiple large RCTs and/or systematic reviews consistently support the benefit |
High confidence the effect is real and clinically meaningful |
| Moderate |
Several RCTs show benefit, but with some inconsistency, small sample sizes, or limited populations |
The effect likely exists but magnitude or applicability may be uncertain |
| Weak |
Limited RCTs, mostly observational data, or conflicting results |
The evidence is insufficient to confidently recommend |
| None |
No credible evidence supports the claim, or well-designed studies show no effect |
The supplement does not work for this purpose based on current evidence |
Vitamins
Vitamin D
| Attribute |
Details |
| Evidence for bone health |
Strong |
| Evidence for immune function |
Moderate |
| Evidence for mood/depression |
Weak to Moderate |
| Evidence for cancer prevention |
Weak |
| RDA |
600 IU (15 mcg) ages 1-70; 800 IU (20 mcg) ages 71+ |
| Upper limit |
4,000 IU (100 mcg)/day |
| Who needs it |
People with limited sun exposure, dark skin tones at high latitudes, older adults, exclusively breastfed infants, those with malabsorption conditions |
| Drug interactions |
Corticosteroids (reduce absorption), orlistat (reduce absorption), statins (possible interaction), thiazide diuretics (hypercalcemia risk) |
| Notes |
Deficiency is widespread globally, affecting an estimated 1 billion people. Blood level of 25(OH)D below 20 ng/mL indicates deficiency. Testing is recommended before high-dose supplementation. |
Vitamin B12
| Attribute |
Details |
| Evidence for deficiency correction |
Strong |
| Evidence for energy in non-deficient people |
None |
| RDA |
2.4 mcg/day (adults) |
| Upper limit |
None established (low toxicity) |
| Who needs it |
Vegans (no dietary source), adults over 50 (reduced absorption), metformin users, those with pernicious anemia, post-bariatric surgery patients |
| Drug interactions |
Metformin (reduces absorption), proton pump inhibitors (reduce absorption), H2 receptor antagonists (reduce absorption) |
| Notes |
B12 deficiency can cause irreversible neurological damage if untreated. Vegans must supplement. |
Vitamin C
| Attribute |
Details |
| Evidence for scurvy prevention |
Strong |
| Evidence for cold prevention |
Weak (may reduce duration by 8% in regular supplementers) |
| Evidence for cold treatment (once sick) |
None |
| RDA |
90 mg (men), 75 mg (women); smokers add 35 mg |
| Upper limit |
2,000 mg/day |
| Who needs it |
Smokers, those with very low fruit/vegetable intake, scurvy risk populations |
| Drug interactions |
May increase estrogen levels from oral contraceptives; high doses may interfere with certain lab tests |
| Notes |
Megadose supplementation (1,000+ mg) provides no additional benefit for most people and is excreted in urine. Food sources easily meet needs. |
Folate (Vitamin B9)
| Attribute |
Details |
| Evidence for neural tube defect prevention |
Strong |
| Evidence for cardiovascular benefit |
Weak |
| RDA |
400 mcg DFE (adults); 600 mcg (pregnancy) |
| Upper limit |
1,000 mcg/day from supplements (may mask B12 deficiency) |
| Who needs it |
Women of childbearing age (before and during pregnancy), individuals with MTHFR variants (methylfolate form), those with malabsorption |
| Drug interactions |
Methotrexate (antagonistic relationship), anti-seizure medications (phenytoin, carbamazepine) |
| Notes |
One of the few supplements with universal recommendation for a specific population (women who may become pregnant). Grain fortification programs have significantly reduced neural tube defects. |
Vitamin A
| Attribute |
Details |
| Evidence for deficiency correction (developing world) |
Strong |
| Evidence for supplementation in well-nourished populations |
None |
| RDA |
900 mcg RAE (men), 700 mcg RAE (women) |
| Upper limit |
3,000 mcg RAE/day (preformed vitamin A); no limit for beta-carotene from food |
| Who needs it |
Malnourished populations, those with fat malabsorption conditions |
| Drug interactions |
Retinoids (isotretinoin, tretinoin — additive toxicity risk), warfarin (may interact) |
| Notes |
Excess preformed vitamin A (retinol) is toxic and teratogenic. The CARET trial showed that beta-carotene supplementation increased lung cancer risk in smokers. Do not supplement unless deficient. |
Vitamin K2
| Attribute |
Details |
| Evidence for bone health |
Moderate (primarily from Japanese studies using MK-4) |
| Evidence for cardiovascular health |
Weak to Moderate |
| RDA |
No separate RDA; vitamin K AI is 120 mcg (men), 90 mcg (women) |
| Who needs it |
Possibly those on long-term antibiotics, those with malabsorption, those supplementing high-dose vitamin D |
| Drug interactions |
Warfarin — critical interaction; vitamin K directly antagonizes warfarin. Patients on warfarin must maintain consistent vitamin K intake and consult their physician before any supplementation |
| Notes |
Emerging evidence for MK-7 form directing calcium to bones rather than arteries, but large-scale RCTs are limited. |
Minerals
Iron
| Attribute |
Details |
| Evidence for deficiency correction |
Strong |
| Evidence for supplementation in non-deficient people |
None (potentially harmful) |
| RDA |
8 mg (men), 18 mg (premenopausal women), 27 mg (pregnancy) |
| Upper limit |
45 mg/day |
| Who needs it |
Premenopausal women with heavy periods, pregnant women, vegetarians/vegans, frequent blood donors, diagnosed iron deficiency anemia |
| Drug interactions |
Reduces absorption of levothyroxine, tetracycline antibiotics, fluoroquinolones, bisphosphonates, levodopa. Take 2+ hours apart. |
| Notes |
Iron is one of the few minerals where excess is clearly harmful. Do not supplement without confirmed deficiency or risk factors. Excess iron increases oxidative stress and is associated with increased cardiovascular risk and liver damage (hemochromatosis). |
Magnesium
| Attribute |
Details |
| Evidence for deficiency-related symptoms |
Strong |
| Evidence for sleep improvement |
Weak to Moderate |
| Evidence for muscle cramps |
Weak |
| Evidence for migraine prevention |
Moderate |
| RDA |
400-420 mg (men), 310-320 mg (women) |
| Upper limit |
350 mg/day from supplements (GI side effects) |
| Who needs it |
Those with inadequate dietary intake (estimated 50% of US adults get less than the EAR), type 2 diabetics (increased urinary loss), heavy alcohol users, those on proton pump inhibitors |
| Drug interactions |
Bisphosphonates (reduced absorption), antibiotics (tetracyclines, fluoroquinolones), diuretics (thiazides reduce loss; loop diuretics increase loss) |
| Notes |
Magnesium glycinate and magnesium citrate have better bioavailability than magnesium oxide. Subclinical deficiency is common and underdiagnosed because serum magnesium (the standard test) reflects only 1% of total body magnesium. |
Zinc
| Attribute |
Details |
| Evidence for cold duration reduction (lozenges) |
Moderate |
| Evidence for immune function in deficiency |
Strong |
| Evidence for testosterone in non-deficient males |
None |
| RDA |
11 mg (men), 8 mg (women) |
| Upper limit |
40 mg/day |
| Who needs it |
Vegetarians/vegans (phytate reduces absorption), older adults, those with GI conditions affecting absorption |
| Drug interactions |
Reduces absorption of tetracycline and fluoroquinolone antibiotics, penicillamine. Competes with copper at high doses. |
| Notes |
Chronic zinc supplementation above 40 mg/day can cause copper deficiency. Zinc lozenges (not pills) specifically have evidence for reducing cold duration. |
Calcium
| Attribute |
Details |
| Evidence for bone health (with vitamin D) |
Strong |
| Evidence for supplementation vs dietary calcium |
Moderate (dietary sources preferred) |
| RDA |
1,000 mg (19-50), 1,200 mg (women 51+, men 71+) |
| Upper limit |
2,500 mg/day (19-50), 2,000 mg (51+) |
| Who needs it |
Those with very low dairy intake and no alternative calcium sources, postmenopausal women, those on long-term corticosteroids |
| Drug interactions |
Reduces absorption of thyroid medications, tetracyclines, fluoroquinolones, bisphosphonates. Separate by 2+ hours. |
| Notes |
Some meta-analyses have raised concerns about calcium supplements (not dietary calcium) and cardiovascular risk (Bolland et al., 2010). Dietary calcium from food is preferred when possible. Split doses (500 mg or less at a time) improve absorption. |
Selenium
| Attribute |
Details |
| Evidence for thyroid function support |
Moderate |
| Evidence for cancer prevention |
Weak (SELECT trial showed no benefit; possible prostate cancer risk increase with supplementation in selenium-replete men) |
| RDA |
55 mcg/day |
| Upper limit |
400 mcg/day |
| Who needs it |
Populations in selenium-poor soil regions, those with Hashimoto's thyroiditis (evidence is moderate for reducing TPO antibodies) |
| Drug interactions |
May interact with cisplatin and other chemotherapy agents |
| Notes |
Brazil nuts are the richest food source (1 nut provides roughly 70-90 mcg). The narrow therapeutic window means supplementation carries real overdose risk. |
Omega-3 Fatty Acids (Fish Oil)
| Attribute |
Details |
| Evidence for triglyceride reduction (high dose) |
Strong (2-4 g EPA+DHA) |
| Evidence for cardiovascular event reduction |
Moderate (REDUCE-IT trial with icosapent ethyl; general fish oil supplements show weaker results) |
| Evidence for joint inflammation (rheumatoid arthritis) |
Moderate |
| Evidence for depression (adjunct therapy) |
Weak to Moderate |
| Evidence for general population "heart health" |
Weak |
| Adequate intake |
250-500 mg combined EPA+DHA per day (most guidelines) |
| Upper limit |
FDA considers up to 3 g/day safe; EFSA up to 5 g/day |
| Who needs it |
People who do not eat fatty fish at least twice per week, those with elevated triglycerides (prescription omega-3), vegans (algae-based DHA) |
| Drug interactions |
Anticoagulants (warfarin, aspirin) — may increase bleeding risk at high doses; antiplatelet drugs |
| Notes |
The VITAL trial (2019) found no significant cardiovascular benefit from 840 mg/day EPA+DHA in the general population. The REDUCE-IT trial (2019) found significant benefit from 4 g/day icosapent ethyl (pure EPA) in high-risk patients. The distinction between general fish oil supplements and pharmaceutical-grade preparations matters. |
Herbal and Botanical Supplements
Ashwagandha (Withania somnifera)
| Attribute |
Details |
| Evidence for stress/anxiety reduction |
Moderate |
| Evidence for testosterone increase |
Weak |
| Evidence for muscle strength (with resistance training) |
Weak to Moderate |
| Typical dose |
300-600 mg root extract/day (standardized to withanolides) |
| Drug interactions |
Thyroid medications (may increase thyroid hormone levels), immunosuppressants (may stimulate immune function), sedatives (additive) |
| Notes |
Several small RCTs show cortisol reduction and anxiety improvement, but most studies are small, short, and from a limited number of research groups. |
Curcumin/Turmeric
| Attribute |
Details |
| Evidence for joint pain (osteoarthritis) |
Moderate |
| Evidence for inflammation reduction (CRP) |
Weak to Moderate |
| Evidence for cancer prevention |
Weak (mostly preclinical) |
| Typical dose |
500-2,000 mg/day curcumin extract (with piperine or phospholipid form for absorption) |
| Drug interactions |
Anticoagulants (may increase bleeding risk), diabetes medications (may lower blood sugar), sulfasalazine (may increase levels) |
| Notes |
Curcumin has extremely poor bioavailability. Standard turmeric powder contains only 3% curcumin, and most curcumin is not absorbed. Enhanced formulations (with piperine, phytosome, or nanoparticle delivery) are needed for meaningful blood levels. |
Berberine
| Attribute |
Details |
| Evidence for blood glucose reduction |
Moderate to Strong |
| Evidence for LDL cholesterol reduction |
Moderate |
| Typical dose |
500 mg 2-3x/day (1,000-1,500 mg total) |
| Drug interactions |
Metformin (additive hypoglycemic effect; use cautiously), cyclosporine (increases levels via CYP3A4 inhibition), statins, warfarin |
| Notes |
Sometimes called "nature's metformin." A meta-analysis by Lan et al. (2015) found berberine reduced HbA1c by ~0.71% and fasting glucose by ~18 mg/dL. However, it interacts with many medications through CYP enzyme inhibition. Always consult a physician if on prescription medications. |
Probiotics
| Attribute |
Details |
| Evidence for antibiotic-associated diarrhea prevention |
Strong (Lactobacillus rhamnosus GG, Saccharomyces boulardii) |
| Evidence for IBS symptom improvement |
Moderate (strain-specific) |
| Evidence for general "gut health" |
Weak (vague endpoint) |
| Evidence for immune function |
Weak to Moderate |
| Typical dose |
Highly variable by strain; 1-100 billion CFU/day |
| Drug interactions |
Immunosuppressants (theoretical risk of infection in immunocompromised) |
| Notes |
Probiotic evidence is extremely strain-specific. Lactobacillus rhamnosus GG is not interchangeable with Lactobacillus acidophilus. "Probiotic" as a category is too broad for meaningful evidence claims. The specific strain, dose, and condition must all match the evidence. |
Sports and Performance Supplements
Creatine Monohydrate
| Attribute |
Details |
| Evidence for strength/power output |
Strong |
| Evidence for lean mass gains (with training) |
Strong |
| Evidence for cognitive function (in sleep deprivation/vegetarians) |
Moderate |
| Evidence for endurance performance |
Weak |
| Typical dose |
3-5 g/day (maintenance); 20 g/day x 5-7 days (loading, optional) |
| Upper limit |
No established UL; long-term studies up to 5 years show no adverse effects at 3-5 g/day |
| Drug interactions |
Theoretically nephrotoxic drugs (no evidence of kidney harm in healthy individuals, but caution with pre-existing kidney disease) |
| Notes |
Creatine monohydrate is the most researched and cost-effective sports supplement in existence, backed by over 500 studies. It is safe, effective, and inexpensive. Claims about creatine causing kidney damage or dehydration have been thoroughly debunked in healthy populations. Other forms (creatine HCl, buffered creatine) offer no proven advantages over monohydrate. |
Caffeine
| Attribute |
Details |
| Evidence for endurance performance |
Strong |
| Evidence for strength/power performance |
Moderate |
| Evidence for cognitive alertness |
Strong |
| Evidence for fat oxidation |
Moderate |
| Typical ergogenic dose |
3-6 mg/kg body weight, 30-60 minutes pre-exercise |
| Upper limit |
FDA recommends no more than 400 mg/day for most adults |
| Drug interactions |
Adenosine (antagonism), MAOIs, ephedrine (dangerous combination), lithium (increases excretion) |
| Notes |
Caffeine is the most widely consumed psychoactive substance in the world and the most well-evidenced ergogenic aid. Individual response varies widely based on CYP1A2 genotype (fast vs slow metabolizers). |
Beta-Alanine
| Attribute |
Details |
| Evidence for exercise capacity (1-4 minute efforts) |
Moderate to Strong |
| Evidence for longer endurance |
Weak |
| Typical dose |
3.2-6.4 g/day (split doses to reduce paresthesia) |
| Drug interactions |
None significant known |
| Notes |
Increases intramuscular carnosine, buffering hydrogen ions during high-intensity exercise. The tingling sensation (paresthesia) is harmless. Benefits are most pronounced in activities lasting 1-4 minutes. |
Protein Supplements (Whey, Casein, Plant)
| Attribute |
Details |
| Evidence for muscle protein synthesis |
Strong (when total daily protein is matched, whole food protein is equivalent) |
| Evidence for convenience in meeting protein targets |
Strong (practical benefit) |
| Typical dose |
20-40 g per serving |
| Drug interactions |
May reduce absorption of levodopa and certain antibiotics if taken simultaneously |
| Notes |
Protein supplements are food, not drugs. They are useful when whole food protein is inconvenient, but they provide no magical advantage over chicken, fish, eggs, or dairy at equivalent protein amounts. Whey has the fastest absorption; casein is slowest. Plant blends (pea + rice) approximate the amino acid profile of whey. |
Drug Interactions: Quick Reference Table
| Supplement |
Interacts With |
Effect |
| Vitamin K |
Warfarin |
Reduces anticoagulant effect |
| Vitamin E (high dose) |
Warfarin, aspirin |
Increases bleeding risk |
| Iron |
Levothyroxine, antibiotics |
Reduces drug absorption |
| Calcium |
Thyroid meds, antibiotics, bisphosphonates |
Reduces drug absorption |
| Magnesium |
Antibiotics, bisphosphonates |
Reduces drug absorption |
| Fish oil (high dose) |
Warfarin, antiplatelet drugs |
Increases bleeding risk |
| St. John's Wort |
SSRIs, oral contraceptives, cyclosporine, HIV meds |
Reduces drug levels (CYP3A4 induction); serotonin syndrome risk with SSRIs |
| Berberine |
Metformin, cyclosporine, statins |
Additive effects or increased drug levels |
| Curcumin |
Anticoagulants, diabetes meds |
Additive bleeding or hypoglycemia risk |
| Ginkgo biloba |
Anticoagulants, antiplatelet drugs |
Increases bleeding risk |
| Vitamin D |
Thiazide diuretics |
Hypercalcemia risk |
| Zinc |
Penicillamine, antibiotics |
Reduces drug absorption |
Critical rule: Always inform your physician about all supplements you take. Supplement-drug interactions can be clinically significant, and many patients do not disclose supplement use to their doctors.
When Supplements Are Actually Needed
Clear Evidence of Need
- Vitamin B12 for vegans (no dietary source)
- Vitamin D for people with confirmed deficiency or very limited sun exposure
- Folate for women who may become pregnant (neural tube defect prevention)
- Iron for diagnosed iron deficiency anemia
- Prenatal multivitamin during pregnancy
- Omega-3 (DHA) for vegans who eat no algae
- Vitamin B12 for adults over 50 (reduced absorption of food-bound B12)
Likely Beneficial for Specific Populations
- Creatine for strength athletes and those doing high-intensity training
- Caffeine for endurance and strength performance
- Magnesium for those with inadequate dietary intake (very common)
- Probiotics (specific strains) during and after antibiotic courses
- Calcium + Vitamin D for postmenopausal women at osteoporosis risk
Probably Unnecessary for Most People
- Multivitamins (if diet is reasonably varied; USPSTF found insufficient evidence to recommend for disease prevention)
- Vitamin C megadoses (food sources easily meet needs)
- Biotin (deficiency is extremely rare)
- Collagen supplements (evidence is limited and preliminary)
- Most herbal "detox" products (the liver and kidneys handle detoxification)
- BCAAs (redundant if total protein intake is adequate from whole protein sources)
Using Nutrola to Identify Real Gaps
The most rational approach to supplementation starts with understanding what your diet already provides. When you consistently track your food intake in Nutrola, you can identify genuine nutritional gaps rather than supplementing blindly. If your tracking data shows consistent shortfalls in vitamin D-rich foods, omega-3 sources, or calcium-rich foods, targeted supplementation for those specific nutrients makes evidence-based sense. If your diet already provides adequate amounts, additional supplementation is unlikely to provide benefit and may carry unnecessary cost or interaction risk.
Frequently Asked Questions
Do I need a daily multivitamin?
For most adults eating a reasonably varied diet, a daily multivitamin is unnecessary. The US Preventive Services Task Force (USPSTF) concluded in 2022 that there is insufficient evidence to recommend multivitamin supplementation for the prevention of cardiovascular disease or cancer. That said, a basic multivitamin is unlikely to cause harm and may serve as a low-cost insurance policy for those with dietary limitations.
What is the most evidence-backed supplement?
For athletic performance, creatine monohydrate has the strongest evidence base of any sports supplement, supported by over 500 studies. For general health, vitamin D supplementation in deficient individuals has robust evidence for bone health and likely immune function benefits. Folate supplementation for women who may become pregnant has unequivocal evidence for neural tube defect prevention.
Can supplements replace a healthy diet?
No. Supplements cannot replicate the complex matrix of nutrients, fiber, phytochemicals, and food components found in whole foods. Multiple large trials of individual nutrient supplements (beta-carotene, vitamin E, selenium) have failed to replicate the disease-prevention benefits observed in people who eat nutrient-rich diets. The "whole food matrix" hypothesis suggests that nutrients work synergistically in food in ways that isolated supplements cannot reproduce.
Are expensive supplements better than cheap ones?
Not necessarily. For well-characterized supplements like vitamin D, creatine monohydrate, and fish oil, generic products from reputable manufacturers that carry third-party testing certification (USP, NSF, ConsumerLab) are equally effective and often significantly cheaper. Premium branding does not guarantee superior quality. Third-party testing certification is more important than price.
How do I know if a supplement is safe and contains what the label claims?
Look for third-party testing certifications: USP (United States Pharmacopeia), NSF International, or ConsumerLab verification. These organizations independently test supplements to verify that they contain what the label claims and are free from harmful contaminants. The supplement industry is not as strictly regulated as pharmaceuticals, and studies have found that some products do not contain the labeled amounts of active ingredients.
Should I take supplements with food or on an empty stomach?
Fat-soluble vitamins (A, D, E, K) should be taken with a meal containing fat for optimal absorption. Iron is best absorbed on an empty stomach, though this increases GI side effects and it can be taken with food if needed. Magnesium, calcium, and most other minerals can be taken with or without food. Follow the specific directions for each supplement.
Conclusion
Dietary supplements occupy a space between food and medicine, and they should be approached with the rigor of both disciplines. The evidence supports targeted supplementation for specific deficiencies and specific populations, and it supports a handful of performance supplements with robust research behind them. For the majority of supplements marketed to the general public, the evidence is either weak, absent, or applicable only to narrow populations.
The most cost-effective and health-protective strategy is to build the best diet you can from whole foods, identify genuine nutritional gaps through consistent tracking with a tool like Nutrola, and supplement only those specific gaps with evidence-backed products at appropriate doses. This targeted approach is safer, cheaper, and more effective than the scattershot supplementation that supplement marketing encourages.
References:
- NIH Office of Dietary Supplements. Fact sheets for health professionals. https://ods.od.nih.gov/
- US Preventive Services Task Force. (2022). Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer. JAMA, 327(23), 2326-2333.
- Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ, 341, c3691.
- Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., ... & Lopez, H. L. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14(1), 18.
- Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., & Sun, G. (2015). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 161, 69-81.
- Manson, J. E., Cook, N. R., Lee, I. M., Christen, W., Bassuk, S. S., Mora, S., ... & VITAL Research Group. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380(1), 33-44.